8-KEarnings & ResultsExhibits & Filings

CVS HEALTH Corp 8-K Report, Financial Results (Feb 8, 2012)

Filed February 8, 2012For Securities:CVS

Summary

This Form 8-K filing from CVS Caremark Corporation, dated February 8, 2012, primarily serves to announce the company's financial results for the fourth quarter and full year ended December 31, 2011. The report itself does not contain the detailed financial data but rather attaches a press release (Exhibit 99.1) that provides these results. Investors should refer to the press release for specific operational and financial condition details for the period. This filing is a standard disclosure mechanism for material events, in this case, the release of quarterly and annual earnings. While the 8-K itself is brief, the attached press release is the critical document for understanding CVS Caremark's performance and financial standing as of the end of 2011. The filing indicates that the information furnished is not being incorporated into any future SEC registration statements unless specifically referenced, which is typical for earnings release filings.

Key Highlights

  • 1CVS Caremark Corporation filed an 8-K on February 8, 2012, to report its financial results.
  • 2The report covers the fourth quarter and the full year ended December 31, 2011.
  • 3The detailed financial results are provided in an attached press release (Exhibit 99.1).
  • 4The filing acts as a formal notification of earnings release to investors and the market.
  • 5David M. Denton, Executive Vice President and Chief Financial Officer, signed the report.
  • 6The information furnished is not automatically incorporated into future SEC filings.
  • 7The company's principal executive offices are located in Woonsocket, Rhode Island.

Frequently Asked Questions

The main purpose of this Form 8-K filing is to officially announce and provide access to CVS Caremark Corporation's financial results for the fourth quarter and the full year ended December 31, 2011.

The detailed financial results are not included directly in the 8-K filing itself. They are provided in a press release dated February 8, 2012, which is attached as Exhibit 99.1 to this report.

This 8-K filing, as an earnings release announcement, would typically have contained forward-looking statements and guidance within the attached press release (Exhibit 99.1). However, the provided text of the 8-K does not detail the content of the press release, so investors should refer directly to Exhibit 99.1 for that specific information.

David M. Denton is identified as the Executive Vice President and Chief Financial Officer of CVS Caremark Corporation. He signed this 8-K report on behalf of the company, indicating his authorization for the filing of these financial results.